Track the Algernon Pharmaceuticals Inc. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares are quoted on CA CA, under the supervision of SEDI. The latest transaction was filed on 2 August 2024 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Moreau, Christopher. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Algernon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing new treatments for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.